Exhibit 99.1
OMNIVISION REPORTS FINANCIAL RESULTS
FOR THE SECOND QUARTER OF FISCAL 2014
SANTA CLARA, Calif., — December 3, 2013 — OmniVision Technologies, Inc. (Nasdaq: OVTI), a leading developer of advanced digital imaging solutions, today reported financial results for the second quarter of fiscal 2014 that ended on October 31, 2013.
Revenues for the second quarter of fiscal 2014 were $397.2 million, as compared to $373.7 million in the first quarter of fiscal 2014, and $390.1 million in the second quarter of fiscal 2013. GAAP net income in the second quarter of fiscal 2014 was $26.3 million, or $0.47 per diluted share, as compared to net income of $23.1 million, or $0.42 per diluted share in the first quarter of fiscal 2014, and $10.3 million, or $0.19 per diluted share in the second quarter of fiscal 2013.
Non-GAAP net income in the second quarter of fiscal 2014 was $34.9 million, or $0.60 per diluted share. Non-GAAP net income in the first quarter of fiscal 2014 was $31.7 million, or $0.55 per diluted share. Non-GAAP net income in the second quarter of fiscal 2013 was $18.6 million, or $0.33 per diluted share. Non-GAAP net income excludes stock-based compensation expenses and the related tax effects. Please refer to the attached schedule for a reconciliation of GAAP net income to non-GAAP net income for the three and six months ended October 31, 2013 and 2012 and for the three months ended July 31, 2013.
GAAP gross margin for the second quarter of fiscal 2014 was 18.8%, as compared to 17.4% for the first quarter of fiscal 2014 and 16.6% for the second quarter of fiscal 2013. The sequential increase in second quarter gross margin reflected production cost improvements in some of our high-volume devices, coupled by a decrease in allowance for excess and obsolete inventories and an increase in revenues recorded on the sale of previously written-down inventory.
The Company ended the period with cash, cash equivalents and short-term investments totaling $265.6 million, an increase of $25.1 million from the previous quarter. The increase was primarily attributable to cash provided by operating activities in the second quarter of fiscal 2014.
“In the second quarter of fiscal 2014, OmniVision grew revenues in the midst of a slowing smartphone market and intensifying competition. We are happy to report sequential improvements in our gross margin, cash, as well as inventory turns,” said Shaw Hong, chief
executive officer of OmniVision Technologies, Inc. “We are also excited about the recent launch of our next generation PureCel sensors. While end-market demand remains volatile, our scale, technology and product portfolio should position us well to weather such volatility over the coming years.”
Outlook
Based on current trends, the Company expects revenues for the third quarter of fiscal 2014 will be in the range of $310 million to $340 million and GAAP net income per share will be between $0.14 and $0.30 per diluted share. Excluding the estimated expense and related tax effects associated with stock-based compensation, the Company expects its non-GAAP net income per share will be between $0.28 and $0.44 per diluted share. Refer to the table below for a reconciliation of GAAP to non-GAAP net income.
Conference Call
OmniVision Technologies, Inc. will host a conference call today at 5:00 p.m. Eastern time to discuss these results further. This conference call can be accessed via a webcast at www.ovt.com. The call can also be accessed by dialing 866-271-5140 (domestic) or 617-213-8893 (international) and entering passcode 42196270.
A replay of the call will remain available at www.ovt.com for approximately twelve months. A replay of the call will also be available for one week beginning approximately one hour after the conclusion of the call. To access the replay, dial 888-286-8010 (domestic) or 617-801-6888 (international) and enter passcode 18027390.
About OmniVision
OmniVision Technologies, Inc. is a leading developer of advanced digital imaging solutions. Its CameraChip™ and CameraCubeChip™ products using CameraCubeChip™, OmniBSI™, OmniBSI+™, OmniBSI-2™, OmniPixel®, OmniPixel2™, OmniPixel3™ and OmniPixel3-HS™ technologies are highly integrated, single-chip CMOS image sensors for consumer and commercial applications including mobile phones, tablets and entertainment devices, notebooks and webcams, security and surveillance systems, digital still and video cameras, automotive and medical imaging systems. Additional information is available at www.ovt.com.
Safe Harbor Statement
Certain statements in this press release, including statements regarding our position over the coming years and statements relating to our expectations regarding revenues and earnings per share for the three months ending January 31, 2014 are forward-looking statements. These forward-looking statements are based on management’s current expectations, and certain factors could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, our ability to maintain or increase sales to current key customers and end-users of our products; competition in current and emerging markets for image sensor products, including pricing pressures that could result from competition; our ability to increase the average selling prices or lower the costs associated with the development and manufacture of our new, complex products and technologies; fluctuations of wafer manufacturing costs, manufacturing yields, manufacturing capacity and other manufacturing processes and the impact on gross margins; the continued growth and development of current markets and the emergence of new markets in which we sell, or may sell, our products; fluctuations in sales mix and average selling prices; our ability to timely complete the product development cycle for new sensors; our ability to obtain design wins from various image sensor device manufacturers including manufacturers of mobile phones, tablets and entertainment devices, notebooks and webcams, security and surveillance systems, digital still and video cameras, automotive and medical imaging systems; our dependence on third party wafer foundries and their ability to manufacture our wafers in the required quantities, at acceptable quality, yields and costs, and in a timely manner; our ability to accurately forecast customer demand for our products; the impact of general economic conditions on orders from the end-user customers of our products; the market acceptance of products into which our products are designed; the development, production, introduction and marketing of new products and technology; the occurrence of litigation regarding intellectual property or indemnification claims from our suppliers or customers relating to our intellectual property; our strategic investments and relationships, and other risks detailed from time to time in our Securities and Exchange Commission filings and reports, including, but not limited to, our most recent Annual Report on Form 10-K and recent Quarterly Reports on Form 10-Q. We expressly disclaim any obligation to update information contained in any forward-looking statement.
Use of Non-GAAP Financial Information
To supplement the reader’s overall understanding of both its reported results presented in accordance with U.S. generally accepted accounting principles (“GAAP”) and its outlook, the Company also presents non-GAAP measures of net income and net income per share which are adjusted from results based on GAAP. In particular, the Company excludes stock-based compensation expenses and the related tax effects. The non-GAAP financial measures which the Company discloses also exclude the effects of stock-based compensation on the number of basic and diluted common shares used in calculating non-GAAP basic and diluted net income per share. The Company provides these non-GAAP financial measures to enhance an investor’s overall understanding of its current financial performance and to assess its prospects for the future. These non-GAAP financial measures reflect an additional way of viewing aspects of the Company’s operations that, when viewed with its GAAP results and the accompanying
reconciliations to the corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting the Company’s business. The economic basis for the Company’s decision to use non-GAAP financial measures is that the adjustments to net income did not reflect the on-going relative strength of the Company’s performance. The Company’s objective is to minimize any confusion in the financial markets by providing non-GAAP net income and non-GAAP net income per share measurements and disclosing the related components. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with GAAP.
The Company uses non-GAAP financial measures for internal management purposes to conduct and evaluate its business, when publicly providing its business outlook and to facilitate period-to-period comparisons. The Company views non-GAAP net income per share as a primary indicator of the profitability of its underlying business. In addition, because stock-based compensation is a non-cash expense and is offset in full by a credit to additional paid-in capital, it has no effect on total stockholders’ equity. As the calculation of non-GAAP financial measures differs between companies, the non-GAAP financial measures used by the Company may not be comparable to similarly titled measures used by other companies. Other than stock-based compensation and the related tax effects, these differences may cause the Company’s non-GAAP measures to not be directly comparable to other companies’ non-GAAP measures. Although these non-GAAP financial measures adjust cost, expenses and basic and diluted share items to exclude the accounting treatment of stock-based compensation, they should not be viewed as a non-GAAP presentation reflecting the elimination of the underlying stock-based compensation programs. Thus, the Company’s non-GAAP presentations are not intended to present, and should not be used, as a basis for assessing what its operating results might be if it were to eliminate its stock-based compensation programs. The Company compensates for these limitations by providing full disclosure of the net income and net income per share on a basis prepared in accordance with GAAP to enable investors to consider net income and net income per share determined under GAAP as well as on an adjusted basis, and perform their own analysis, as appropriate. As a result of the foregoing limitations, the Company does not use, nor does the Company intend to use, the non-GAAP financial measures when assessing the Company’s performance against that of other companies.
Estimating stock-based compensation expenses and the related tax effects for a future period is subject to inherent risks and uncertainties, including but not limited to the price of the Company’s stock, stock market volatility, expected option life, risk-free interest rates, and the number of option exercises and sales during the quarter.
OMNIVISION TECHNOLOGIES, INC.
RECONCILIATION OF GUIDANCE FOR GAAP NET INCOME PER DILUTED SHARE
TO PROJECTED NON-GAAP NET INCOME PER DILUTED SHARE
(unaudited)
|
|
|
Three Months Ending January 31, 2014 |
| |||||||||||||
|
|
|
GAAP |
|
|
|
Non-GAAP |
| |||||||||
|
|
|
From |
|
To |
|
Adjustment |
|
From |
|
To |
| |||||
|
Net income per share |
|
$ |
0.14 |
|
$ |
0.30 |
|
$ |
0.14 |
(1) |
$ |
0.28 |
|
$ |
0.44 |
|
(1) Reflects estimated adjustment for expenses and related tax effects associated with stock-based compensation.
OMNIVISION TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
(unaudited)
|
|
|
October 31, |
|
April 30, |
| ||
|
|
|
2013 |
|
2013 |
| ||
|
ASSETS |
|
|
|
|
| ||
|
Current assets: |
|
|
|
|
| ||
|
Cash and cash equivalents |
|
$ |
207,171 |
|
$ |
190,171 |
|
|
Short-term investments |
|
58,427 |
|
22,164 |
| ||
|
Accounts receivable, net |
|
170,871 |
|
166,517 |
| ||
|
Inventories |
|
390,275 |
|
430,315 |
| ||
|
Deferred income taxes |
|
2,554 |
|
4,028 |
| ||
|
Prepaid expenses and other current assets |
|
8,174 |
|
11,982 |
| ||
|
Total current assets |
|
837,472 |
|
825,177 |
| ||
|
Property, plant and equipment, net |
|
157,400 |
|
158,394 |
| ||
|
Long-term investments |
|
145,643 |
|
139,746 |
| ||
|
Goodwill |
|
10,227 |
|
10,227 |
| ||
|
Intangibles, net |
|
50,729 |
|
56,804 |
| ||
|
Other long-term assets |
|
37,413 |
|
36,666 |
| ||
|
Total assets |
|
$ |
1,238,884 |
|
$ |
1,227,014 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
| ||
|
Current liabilities: |
|
|
|
|
| ||
|
Accounts payable |
|
$ |
127,019 |
|
$ |
188,261 |
|
|
Accrued expenses and other current liabilities |
|
42,076 |
|
40,274 |
| ||
|
Income tax payable |
|
195 |
|
2,904 |
| ||
|
Deferred revenues, less cost of revenues |
|
24,791 |
|
15,493 |
| ||
|
Current portion of long-term debt |
|
3,809 |
|
3,769 |
| ||
|
Total current liabilities |
|
197,890 |
|
250,701 |
| ||
|
Long-term liabilities: |
|
|
|
|
| ||
|
Long-term income taxes payable |
|
83,449 |
|
90,777 |
| ||
|
Non-current portion of long-term debt |
|
35,586 |
|
35,709 |
| ||
|
Other long-term liabilities |
|
4,008 |
|
4,618 |
| ||
|
Total long-term liabilities |
|
123,043 |
|
131,104 |
| ||
|
Total liabilities |
|
320,933 |
|
381,805 |
| ||
|
|
|
|
|
|
| ||
|
Stockholders’ equity: |
|
|
|
|
| ||
|
Common stock, $0.001 par value; 100,000 shares authorized; 76,213 shares issued and 55,614 outstanding at October 31, 2013 and 74,574 shares issued and 53,975 outstanding at April 30, 2013, respectively |
|
76 |
|
75 |
| ||
|
Additional paid-in capital |
|
640,432 |
|
616,379 |
| ||
|
Accumulated other comprehensive income |
|
3,276 |
|
3,952 |
| ||
|
Treasury stock, 20,599 at October 31, 2013 and April 30, 2013, respectively |
|
(278,683 |
) |
(278,683 |
) | ||
|
Retained earnings |
|
552,850 |
|
503,486 |
| ||
|
Total stockholders’ equity |
|
917,951 |
|
845,209 |
| ||
|
Total liabilities and stockholders’ equity |
|
$ |
1,238,884 |
|
$ |
1,227,014 |
|
OMNIVISION TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share amounts)
(unaudited)
|
|
|
Three Months Ended |
|
Six Months Ended |
| ||||||||
|
|
|
October 31, |
|
October 31, |
| ||||||||
|
|
|
2013 |
|
2012 |
|
2013 |
|
2012 |
| ||||
|
Revenues |
|
$ |
397,249 |
|
$ |
390,137 |
|
$ |
770,937 |
|
$ |
648,201 |
|
|
Cost of revenues |
|
322,383 |
|
325,453 |
|
630,910 |
|
534,302 |
| ||||
|
Gross profit |
|
74,866 |
|
64,684 |
|
140,027 |
|
113,899 |
| ||||
|
|
|
|
|
|
|
|
|
|
| ||||
|
Operating expenses: |
|
|
|
|
|
|
|
|
| ||||
|
Research, development and related |
|
29,123 |
|
30,361 |
|
56,825 |
|
59,209 |
| ||||
|
Selling, general and administrative |
|
18,456 |
|
18,131 |
|
36,656 |
|
36,859 |
| ||||
|
Amortization of acquired patent portfolio |
|
2,322 |
|
2,322 |
|
4,643 |
|
4,643 |
| ||||
|
Total operating expenses |
|
49,901 |
|
50,814 |
|
98,124 |
|
100,711 |
| ||||
|
|
|
|
|
|
|
|
|
|
| ||||
|
Income from operations |
|
24,965 |
|
13,870 |
|
41,903 |
|
13,188 |
| ||||
|
Equity in earnings of investee |
|
1,317 |
|
1,192 |
|
2,427 |
|
2,332 |
| ||||
|
Interest expense, net |
|
(535 |
) |
(728 |
) |
(1,076 |
) |
(1,486 |
) | ||||
|
Other income, net |
|
2,345 |
|
222 |
|
1,168 |
|
316 |
| ||||
|
Income before income taxes |
|
28,092 |
|
14,556 |
|
44,422 |
|
14,350 |
| ||||
|
|
|
|
|
|
|
|
|
|
| ||||
|
Provision for (benefit from) income taxes |
|
1,789 |
|
4,211 |
|
(4,942 |
) |
1,678 |
| ||||
|
Net income |
|
$ |
26,303 |
|
$ |
10,345 |
|
$ |
49,364 |
|
$ |
12,672 |
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
Net income per share: |
|
|
|
|
|
|
|
|
| ||||
|
Basic |
|
$ |
0.47 |
|
$ |
0.19 |
|
$ |
0.90 |
|
$ |
0.24 |
|
|
Diluted |
|
$ |
0.47 |
|
$ |
0.19 |
|
$ |
0.89 |
|
$ |
0.24 |
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
Shares used in computing net income per share: |
|
|
|
|
|
|
|
|
| ||||
|
Basic |
|
55,584 |
|
53,514 |
|
55,098 |
|
53,172 |
| ||||
|
Diluted |
|
55,732 |
|
53,675 |
|
55,453 |
|
53,310 |
| ||||
OMNIVISION TECHNOLOGIES, INC.
RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME
(in thousands, except per share amounts)
(unaudited)
|
|
|
Three Months Ended |
|
Six Months Ended |
|
Three Months |
| |||||||||
|
|
|
October 31, |
|
October 31, |
|
July 31, |
| |||||||||
|
|
|
2013 |
|
2012 |
|
2013 |
|
2012 |
|
2013 |
| |||||
|
GAAP net income |
|
$ |
26,303 |
|
$ |
10,345 |
|
$ |
49,364 |
|
$ |
12,672 |
|
$ |
23,061 |
|
|
Add: |
|
|
|
|
|
|
|
|
|
|
| |||||
|
Stock-based compensation in cost of revenues |
|
985 |
|
977 |
|
1,957 |
|
2,037 |
|
972 |
| |||||
|
Stock-based compensation in research, development and related expenses |
|
3,936 |
|
4,113 |
|
7,730 |
|
8,865 |
|
3,794 |
| |||||
|
Stock-based compensation in selling, general and administrative expenses |
|
3,552 |
|
3,344 |
|
7,282 |
|
7,060 |
|
3,730 |
| |||||
|
(Increase) decrease in provision for (benefit from) income taxes without the effect of stock-based compensation |
|
159 |
|
(228 |
) |
329 |
|
(522 |
) |
170 |
| |||||
|
Non-GAAP net income |
|
$ |
34,935 |
|
$ |
18,551 |
|
$ |
66,662 |
|
$ |
30,112 |
|
$ |
31,727 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
GAAP provision for (benefit from) income taxes |
|
$ |
1,789 |
|
$ |
4,211 |
|
$ |
(4,942 |
) |
$ |
1,678 |
|
$ |
(6,731 |
) |
|
(Increase) decrease in provision for (benefit from) income taxes without the effect of stock-based compensation |
|
159 |
|
(228 |
) |
329 |
|
(522 |
) |
170 |
| |||||
|
Non-GAAP provision for (benefit from) income taxes |
|
$ |
1,630 |
|
$ |
4,439 |
|
$ |
(5,271 |
) |
$ |
2,200 |
|
$ |
(6,901 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
Non-GAAP net income per share: |
|
|
|
|
|
|
|
|
|
|
| |||||
|
Basic |
|
$ |
0.63 |
|
$ |
0.35 |
|
$ |
1.21 |
|
$ |
0.57 |
|
$ |
0.58 |
|
|
Diluted |
|
$ |
0.60 |
|
$ |
0.33 |
|
$ |
1.15 |
|
$ |
0.54 |
|
$ |
0.55 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
Shares used in computing non-GAAP net income per share: |
|
|
|
|
|
|
|
|
|
|
| |||||
|
Basic |
|
55,584 |
|
53,514 |
|
55,098 |
|
53,172 |
|
54,611 |
| |||||
|
Diluted |
|
58,649 |
|
56,211 |
|
58,083 |
|
55,695 |
|
57,509 |
| |||||
Contact Information
Investor Relations:
Arnab Chanda
OmniVision Technologies, Inc.
408.653.3144
invest@ovt.com